Home > Publications database > Ascites of patients with solid tumors shows distinct inflammatory patterns. > print |
001 | 301268 | ||
005 | 20250904115951.0 | ||
024 | 7 | _ | |a pmid:40344395 |2 pmid |
024 | 7 | _ | |a 1000-467X |2 ISSN |
024 | 7 | _ | |a 1944-446X |2 ISSN |
024 | 7 | _ | |a 2523-3548 |2 ISSN |
024 | 7 | _ | |a DOI:10.1002/cac2.70031 |2 doi |
024 | 7 | _ | |a DOI:10.1002/cac2.70031 |2 doi |
037 | _ | _ | |a DKFZ-2025-00953 |
041 | _ | _ | |a English |
082 | _ | _ | |a 610 |
100 | 1 | _ | |a Berger, Julia M |0 0000-0002-1695-8577 |b 0 |
245 | _ | _ | |a Ascites of patients with solid tumors shows distinct inflammatory patterns. |
260 | _ | _ | |a Hoboken, NJ |c 2025 |b Wiley |
336 | 7 | _ | |a article |2 DRIVER |
336 | 7 | _ | |a Output Types/Journal article |2 DataCite |
336 | 7 | _ | |a Journal Article |b journal |m journal |0 PUB:(DE-HGF)16 |s 1756979951_27124 |2 PUB:(DE-HGF) |x Letter |
336 | 7 | _ | |a ARTICLE |2 BibTeX |
336 | 7 | _ | |a JOURNAL_ARTICLE |2 ORCID |
336 | 7 | _ | |a Journal Article |0 0 |2 EndNote |
500 | _ | _ | |a Volume 45, Issue 8 pp. 936-940 |
536 | _ | _ | |a 314 - Immunologie und Krebs (POF4-314) |0 G:(DE-HGF)POF4-314 |c POF4-314 |f POF IV |x 0 |
588 | _ | _ | |a Dataset connected to DataCite, PubMed, , Journals: inrepo02.dkfz.de |
700 | 1 | _ | |a Korpan, Martin |b 1 |
700 | 1 | _ | |a Zierfuss, Carina |b 2 |
700 | 1 | _ | |a Syböck, Katharina |b 3 |
700 | 1 | _ | |a Tomasich, Erwin |0 0000-0002-7069-2247 |b 4 |
700 | 1 | _ | |a Kienzle, Andreas |0 P:(DE-He78)e584a92f41b005cab185e57fcc2a0957 |b 5 |u dkfz |
700 | 1 | _ | |a Koenig, Maria |b 6 |
700 | 1 | _ | |a Kleinberger, Markus |b 7 |
700 | 1 | _ | |a Gottmann, Lynn |b 8 |
700 | 1 | _ | |a Fendl, Birgit |b 9 |
700 | 1 | _ | |a Ay, Cihan |b 10 |
700 | 1 | _ | |a Pammer, Johannes |b 11 |
700 | 1 | _ | |a Müller, Catharina |b 12 |
700 | 1 | _ | |a Oehler, Rudolf |b 13 |
700 | 1 | _ | |a Balcar, Lorenz |b 14 |
700 | 1 | _ | |a Reiberger, Thomas |b 15 |
700 | 1 | _ | |a Bergen, Elisabeth S |b 16 |
700 | 1 | _ | |a Niederdorfer, Barbara |b 17 |
700 | 1 | _ | |a Preusser, Matthias |b 18 |
700 | 1 | _ | |a Berghoff, Anna S |b 19 |
773 | _ | _ | |a DOI:10.1002/cac2.70031 |0 PERI:(DE-600)2922913-3 |n 8 |p 936-940 |t Cancer communications |v 45 |y 2025 |x 1000-467X |
909 | C | O | |p VDB |o oai:inrepo02.dkfz.de:301268 |
910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 5 |6 P:(DE-He78)e584a92f41b005cab185e57fcc2a0957 |
913 | 1 | _ | |a DE-HGF |b Gesundheit |l Krebsforschung |1 G:(DE-HGF)POF4-310 |0 G:(DE-HGF)POF4-314 |3 G:(DE-HGF)POF4 |2 G:(DE-HGF)POF4-300 |4 G:(DE-HGF)POF |v Immunologie und Krebs |x 0 |
914 | 1 | _ | |y 2025 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0300 |2 StatID |b Medline |d 2023-10-27 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0320 |2 StatID |b PubMed Central |d 2023-10-27 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0501 |2 StatID |b DOAJ Seal |d 2023-05-02T09:05:11Z |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0500 |2 StatID |b DOAJ |d 2023-05-02T09:05:11Z |
915 | _ | _ | |a Peer Review |0 StatID:(DE-HGF)0030 |2 StatID |b DOAJ : Anonymous peer review |d 2023-05-02T09:05:11Z |
915 | _ | _ | |a Creative Commons Attribution CC BY (No Version) |0 LIC:(DE-HGF)CCBYNV |2 V:(DE-HGF) |b DOAJ |d 2023-05-02T09:05:11Z |
915 | _ | _ | |a JCR |0 StatID:(DE-HGF)0100 |2 StatID |b CANCER COMMUN : 2022 |d 2023-10-27 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0200 |2 StatID |b SCOPUS |d 2023-10-27 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0199 |2 StatID |b Clarivate Analytics Master Journal List |d 2023-10-27 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1050 |2 StatID |b BIOSIS Previews |d 2023-10-27 |
915 | _ | _ | |a WoS |0 StatID:(DE-HGF)0113 |2 StatID |b Science Citation Index Expanded |d 2023-10-27 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0150 |2 StatID |b Web of Science Core Collection |d 2023-10-27 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1190 |2 StatID |b Biological Abstracts |d 2023-10-27 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0160 |2 StatID |b Essential Science Indicators |d 2023-10-27 |
915 | _ | _ | |a IF >= 15 |0 StatID:(DE-HGF)9915 |2 StatID |b CANCER COMMUN : 2022 |d 2023-10-27 |
915 | _ | _ | |a Article Processing Charges |0 StatID:(DE-HGF)0561 |2 StatID |d 2023-10-27 |
915 | _ | _ | |a Fees |0 StatID:(DE-HGF)0700 |2 StatID |d 2023-10-27 |
920 | 1 | _ | |0 I:(DE-He78)D410-20160331 |k D410 |l Immuntherapie und -prävention |x 0 |
980 | _ | _ | |a journal |
980 | _ | _ | |a VDB |
980 | _ | _ | |a I:(DE-He78)D410-20160331 |
980 | _ | _ | |a UNRESTRICTED |
Library | Collection | CLSMajor | CLSMinor | Language | Author |
---|